With reference to the Buyback of equity shares of Re 1 each of the company in terms of Securities and Exchange Board of India (Buyback of Securities) Regulations, 2018 (‘SEBI Buyback Regulations’) through open market using the Stock Exchanges Mechanism (‘Buyback’), Marksans Pharma has submitted the daily report pursuant to Regulation 18 of the SEBI Buyback Regulations regarding the Equity Shares bought back on November 1, 2022.
The above information is a part of company’s filings submitted to BSE.